$81.88
-0.92[-1.11%]
Last update: 11:47AM Get Real Time Here
Encompass Health
(NYSE:EHC)Encompass Health Stock (NYSE:EHC), Analyst Ratings, Price Targets, Predictions
Encompass Health Corp has a consensus price target of $82.88, established from looking at the 56 latest analyst ratings. The last 3 analyst ratings were released from Mizuho, Barclays, and Barclays on April 25, 2024, March 28, 2024, and March 6, 2024. With an average price target of $97 between Mizuho, Barclays, and Barclays, there's an implied 14.10% upside for Encompass Health Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Mizuho
Barclays
Truist Securities
RBC Capital
Stephens & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Encompass Health
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/25/2024 | EHC | Buy Now | Encompass Health | $85.01 | 11.75% | Mizuho | Ann Hynes | $93 → $95 | Maintains | Buy | Get Alert |
| 03/28/2024 | EHC | Buy Now | Encompass Health | $85.01 | 18.81% | Barclays | Andrew Mok | $95 → $101 | Maintains | Overweight | Get Alert |
| 03/06/2024 | EHC | Buy Now | Encompass Health | $85.01 | 11.75% | Barclays | Andrew Mok | → $95 | Initiates | → Overweight | Get Alert |
| 02/09/2024 | EHC | Buy Now | Encompass Health | $85.01 | 1.16% | Truist Securities | David Macdonald | $82 → $86 | Maintains | Buy | Get Alert |
| 02/09/2024 | EHC | Buy Now | Encompass Health | $85.01 | -2.36% | RBC Capital | Ben Hendrix | → $83 | Reiterates | Outperform → Outperform | Get Alert |
| 02/09/2024 | EHC | Buy Now | Encompass Health | $85.01 | -3.54% | Mizuho | Ann Hynes | $77 → $82 | Maintains | Buy | Get Alert |
| 01/16/2024 | EHC | Buy Now | Encompass Health | $85.01 | -0.01% | Stephens & Co. | Scott Fidel | → $85 | Reiterates | Overweight → Overweight | Get Alert |
| 09/28/2023 | EHC | Buy Now | Encompass Health | $85.01 | -2.36% | RBC Capital | Ben Hendrix | → $83 | Reiterates | Outperform → Outperform | Get Alert |
| 08/08/2023 | EHC | Buy Now | Encompass Health | $85.01 | -2.36% | RBC Capital | Ben Hendrix | $70 → $83 | Maintains | Outperform | Get Alert |
| 08/04/2023 | EHC | Buy Now | Encompass Health | $85.01 | -17.66% | Barclays | Jason Goldberg | $61 → $70 | Maintains | Equal-Weight | Get Alert |
| 08/04/2023 | EHC | Buy Now | Encompass Health | $85.01 | -5.89% | Credit Suisse | Jonathan Yong | $76 → $80 | Maintains | Outperform | Get Alert |
| 08/03/2023 | EHC | Buy Now | Encompass Health | $85.01 | -0.01% | Raymond James | John Ransom | $80 → $85 | Maintains | Strong Buy | Get Alert |
| 08/03/2023 | EHC | Buy Now | Encompass Health | $85.01 | -3.54% | Truist Securities | David Macdonald | $75 → $82 | Maintains | Buy | Get Alert |
| 08/03/2023 | EHC | Buy Now | Encompass Health | $85.01 | -9.42% | Mizuho | Ann Hynes | $74 → $77 | Maintains | Buy | Get Alert |
| 08/03/2023 | EHC | Buy Now | Encompass Health | $85.01 | -16.48% | Barclays | Jason Goldberg | $61 → $71 | Maintains | Equal-Weight | Get Alert |
| 07/20/2023 | EHC | Buy Now | Encompass Health | $85.01 | -8.25% | Stephens & Co. | Scott Fidel | → $78 | Reiterates | Overweight → Overweight | Get Alert |
| 06/29/2023 | EHC | Buy Now | Encompass Health | $85.01 | -8.25% | Stephens & Co. | Scott Fidel | $74 → $78 | Maintains | Overweight | Get Alert |
| 05/02/2023 | EHC | Buy Now | Encompass Health | $85.01 | -17.66% | RBC Capital | Ben Hendrix | $66 → $70 | Maintains | Outperform | Get Alert |
| 05/02/2023 | EHC | Buy Now | Encompass Health | $85.01 | -5.89% | Raymond James | John Ransom | $72 → $80 | Maintains | Strong Buy | Get Alert |
FAQ
What is the target price for Encompass Health (EHC)?
The latest price target for Encompass Health (NYSE: EHC) was reported by Mizuho on April 25, 2024. The analyst firm set a price target for $95.00 expecting EHC to rise to within 12 months (a possible 16.02% upside). 24 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Encompass Health (EHC)?
The latest analyst rating for Encompass Health (NYSE: EHC) was provided by Mizuho, and Encompass Health maintained their buy rating.
When was the last upgrade for Encompass Health (EHC)?
The last upgrade for Encompass Health Corp happened on August 2, 2021 when Raymond James raised their price target to $107. Raymond James previously had an outperform for Encompass Health Corp.
When was the last downgrade for Encompass Health (EHC)?
There is no last downgrade for Encompass Health.
When is the next analyst rating going to be posted or updated for Encompass Health (EHC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Encompass Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Encompass Health was filed on April 25, 2024 so you should expect the next rating to be made available sometime around April 25, 2025.
Is the Analyst Rating Encompass Health (EHC) correct?
While ratings are subjective and will change, the latest Encompass Health (EHC) rating was a maintained with a price target of $93.00 to $95.00. The current price Encompass Health (EHC) is trading at is $81.88, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.